Clinical usefulness of chlormadinone acetate as an alternative antiandrogen therapy for prostate cancer relapse after combined androgen blockade therapy

Clinical usefulness of chlormadinone acetate as an alternative antiandrogen therapy for prostate cancer relapse after combined androgen blockade therapy

We prospectively studied the usefulness of chlormadinone acetate (CMA) as an alternative therapy for prostate cancer relapse after combined androgen blockade (CAB) therapy. Sixteen patients with relapsed prostate cancer after treatment with CAB, including surgical or medical castration and nonsteroi...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 55(2009), 4 vom: 28. Apr., Seite 199-203
1. Verfasser: Ehara, Hidetoshi (VerfasserIn)
Weitere Verfasser: Katoh, Seichi, Nakane, Keita, Katoh, Taku, Takada, Toshihiko, Kojima, Keitaro, Kamei, Shingo, Hagiwara, Noriyasu, Yuhara, Kazuya, Takahashi, Yoshito, Fujimoto, Yoshinori, Fujihiro, Shigeru, Kanimoto, Yuhsuke, Deguchi, Takashi
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 2009
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:English Abstract Journal Article Androgen Antagonists Chlormadinone Acetate 0SY050L61N